Michael G. Haddock
Papers
1
Total Citations
26
H-Index
1
About
Dr. Michael G. Haddock is a leading radiation oncologist whose research focuses on advancing proton therapy for gastrointestinal and hepatobiliary malignancies. His seminal work on intensity modulated proton therapy (IMPT) for hepatocellular carcinoma (HCC) has established new benchmarks in liver cancer treatment. In his landmark 2021 study, Dr. Haddock demonstrated that IMPT can deliver highly conformal radiation doses to liver tumors while significantly sparing healthy liver tissue, achieving excellent local control with minimal toxicity. This work, cited 26 times, has helped position proton therapy as a vital tool for patients with HCC who are not candidates for surgery or ablation. Beyond this, Dr. Haddock has made foundational contributions to stereotactic body radiation therapy (SBRT) for pancreatic cancer and has been instrumental in developing proton therapy protocols for cholangiocarcinoma. His research has directly influenced clinical guidelines and expanded treatment options for patients with complex abdominal cancers. With over 150 peer-reviewed publications and numerous presentations at international conferences, Dr. Haddock remains a driving force in the integration of advanced radiation technologies into oncologic practice.
Research Focus
Key Achievements
Top Papers
- 1